Analysts Set Colgate-Palmolive (NYSE:CL) PT at $105.11

Colgate-Palmolive (NYSE:CL) has earned a consensus rating of “Moderate Buy” from the twenty-two brokerages that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $105.11.

CL has been the topic of a number of recent research reports. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, October 29th. Morgan Stanley raised their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the company from $107.00 to $109.00 in a report on Monday, September 9th. Finally, Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th.

Colgate-Palmolive Price Performance

NYSE:CL opened at $93.33 on Tuesday. Colgate-Palmolive has a 52 week low of $74.22 and a 52 week high of $109.30. The firm has a market cap of $76.25 billion, a price-to-earnings ratio of 26.74, a P/E/G ratio of 3.38 and a beta of 0.40. The firm’s 50-day simple moving average is $102.26 and its 200 day simple moving average is $98.27. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.28 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling

In related news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now owns 5,146 shares in the company, valued at $529,729.24. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 in the last ninety days. Company insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at $25,000. Continuum Advisory LLC increased its stake in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $53,000. Finally, Gradient Investments LLC increased its stake in shares of Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after acquiring an additional 400 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.